Genotypes and drug susceptibility of Mycobacterium tuberculosis Isolates in Shihezi, Xinjiang Province, China

BMC Research Notes

Li Yuan¹  Bing Lv²  Yi Huang¹  Haiyan Liang¹  Peizhi Liu³  Yuanzhi Wang¹  Ligu Mi¹  Juan Zhang¹ 

[1] Department of Pathogenic Biology and Immunology, School of Medicine, Shi Hezi University, Shihezi, People’s Republic of China;National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, State Key Laboratory for Infectious Disease Prevention and Control, Beijing, People’s Republic of China;The First Hospital of Shi Hezi University, Shihezi, People’s Republic of China

关键词: Xinjiang;    Drug susceptibility test;    Genotype;    Mycobacterium tuberculosis;   

Others  :  1166264
DOI  :  10.1186/1756-0500-5-309

 received in 2012-02-08, accepted in 2012-06-14,  发布年份 2012

【 摘 要 】

Background

Tuberculosis (TB) remains a major global health problem. To investigate the genotypes of Mycobacterium tuberculosis (MTB) and the distribution of Beijing family strains, molecular epidemiology technologies have been used widely.

Methods

From June 2010 to June 2011, 55 M. tuberculosis isolates from patients with pulmonary TB were studied by Beijing family-specific PCR (detection of the deletion of region of difference 105 [RD105]), and mycobacterial interspersed repetitive units variable number tandem repeat (MIRU-VNTR) analysis. Twenty-four MIRU-VNTR loci defined the genotypes and clustering characteristics of the local strains. All strains were subjected to a drug susceptibility test (DST) by the proportion method on Lowenstein-Jensen (LJ) culture media.

Results

Fifty-five clinical isolates of MTB were collected. Beijing family strains represented 85.5% of the isolates studied. Using 24 loci MIRU-VNTR typing categorized the strains into eight gene groups, 46 genotypes, and seven clusters. 83.6% (46/55) of the isolates belonged to the largest gene group. Thirty-six isolates (65.5%) were susceptible, nineteen (34.5%) were resistant to at least one drug, seven (12.8%) were Multidrug-Resistant Tuberculosis (MDR TB), and two (3.6%) were extremely drug-resistant tuberculosis (XDR-TB).

Conclusion

The results showed there were obvious polymorphisms of VNTRs of MTB clinical strains. Beijing family strains of MTB were predominant in the Shihezi region of Xinjiang province. There was no correlation between the drug-resistance and Beijing family strains of MTB. It is necessary to strengthen the monitoring, treatment, and management of drug-resistance TB in Shihezi region, Xinjiang.

【 授权许可】

   
2012 Zhang et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]World Health Organisation: Global tuberculosis control. WHO report; 2011.
• [2]Frothingham R, Meeker-O'Connell WA: Genetic diversity in the Mycobacterium tuberculosis complex based on variable numbers of tandem DNA repeats. Microbiology 1998, 144(Pt 5):1189-1196.
• [3]Supply P, Mazars E, Lesjean S, Vincent V, Gicquel B, Locht C: Variable human minisatellite-like regions in the Mycobacterium tuberculosis genome. Mol Microbiol 2000, 36(3):762-771.
• [4]Alonso-Rodriguez N, Martinez-Lirola M, Herranz M, Sanchez-Benitez M, Barroso P, Bouza E, Garcia DVD: Evaluation of the new advanced 15-loci MIRU-VNTR genotyping tool in Mycobacterium tuberculosis molecular epidemiology studies. BMC Microbiol 2008, 8:34. BioMed Central Full Text
• [5]Christianson S, Wolfe J, Orr P, Karlowsky J, Levett PN, Horsman GB, Thibert L, Tang P, Sharma MK: Evaluation of 24 locus MIRU-VNTR genotyping of Mycobacterium tuberculosis isolates in Canada. Tuberculosis (Edinb) 2010, 90(1):31-38.
• [6]Maes M, Kremer K, van Soolingen D, Takiff H, de Waard JH: 24-locus MIRU-VNTR genotyping is a useful tool to study the molecular epidemiology of tuberculosis among Warao Amerindians in Venezuela. Tuberculosis (Edinb) 2008, 88(5):490-494.
• [7]Sola C, Filliol I, Legrand E, Lesjean S, Locht C, Supply P, Rastogi N: Genotyping of the Mycobacterium tuberculosis complex using MIRUs: association with VNTR and spoligotyping for molecular epidemiology and evolutionary genetics. Infect Genet Evol 2003, 3(2):125-133.
• [8]Supply P, Warren RM, Banuls AL, Lesjean S, Van Der Spuy GD, Lewis LA, Tibayrenc M, Van Helden PD, Locht C: Linkage disequilibrium between minisatellite loci supports clonal evolution of Mycobacterium tuberculosis in a high tuberculosis incidence area. Mol Microbiol 2003, 47(2):529-538.
• [9]Supply P, Lesjean S, Savine E, Kremer K, van Soolingen D, Locht C: Automated high-throughput genotyping for study of global epidemiology of Mycobacterium tuberculosis based on mycobacterial interspersed repetitive units. J Clin Microbiol 2001, 39(10):3563-3571.
• [10]Dickman KR, Nabyonga L, Kateete DP, Katabazi FA, Asiimwe BB, Mayanja HK, Okwera A, Whalen C, Joloba ML: Detection of multiple strains of Mycobacterium tuberculosis using MIRU-VNTR in patients with pulmonary tuberculosis in Kampala. Uganda. Bmc Infect Dis 2010, 10:349.
• [11]Rovina N, Karabela S, Constantoulakis P, Michou V, Konstantinou K, Sgountzos V, Roussos C, Poulakis N: MIRU-VNTR typing of drug-resistant tuberculosis isolates in Greece. Ther Adv Respir Dis 2011, 5(4):229-236.
• [12]Liu Q, Yang D, Xu W, Wang J, Lv B, Shao Y, Song H, Li G, Dong H, Wan K, et al.: Molecular typing of mycobacterium tuberculosis isolates circulating in Jiangsu Province. China. Bmc Infect Dis 2011, 11:288. BioMed Central Full Text
• [13]van Soolingen D, Qian L, de Haas PE, Douglas JT, Traore H, Portaels F, Qing HZ, Enkhsaikan D, Nymadawa P, van Embden JD: Predominance of a single genotype of Mycobacterium tuberculosis in countries of east Asia. J Clin Microbiol 1995, 33(12):3234-3238.
• [14]Rivera-Ordaz A, Gonzaga-Bernachi J, Serafin-Lopez J, Hernandez-Pando R, Van Soolingen D, Estrada-Parra S, Estrada-Garcia I, Chacon-Salinas R: Mycobacterium Tuberculosis Beijing Genotype Induces Differential Cytokine Production by Peripheral Blood Mononuclear Cells of Healthy BCG Vaccinated Individuals. Immunol Invest 2012, 41(2):144-156.
• [15]Hu Y, Hoffner S, Jiang W, Wang W, Xu B: Extensive transmission of isoniazid resistant M. tuberculosis and its association with increased multidrug-resistant TB in two rural counties of eastern China: a molecular epidemiological study. BMC Infect Dis 2010, 10:43. BioMed Central Full Text
• [16]Ma X, Wang H, Deng Y, Liu Z, Xu Y, Pan X, Musser JM, Graviss EA: rpoB Gene mutations and molecular characterization of rifampin-resistant Mycobacterium tuberculosis isolates from Shandong Province, China. J Clin Microbiol 2006, 44(9):3409-3412.
• [17]Wang J, Liu Y, Zhang CL, Ji BY, Zhang LZ, Shao YZ, Jiang SL, Suzuki Y, Nakajima C, Fan CL, et al.: Genotypes and characteristics of clustering and drug susceptibility of Mycobacterium tuberculosis isolates collected in Heilongjiang Province, China. J Clin Microbiol 2011, 49(4):1354-1362.
• [18]Jinghua L, Pourel C, Hauck Y, Xiuqin Z, Zhiguang L, Kanglin W: A new method for the identification of the "Beijing family" strain of Mycobacterium tuberculosis. Chinese Journal of Microbiology and Immunology 2008, 28(2):172-175.
• [19]Tsolaki AG, Gagneux S, Pym AS, Goguet DLSY, Kreiswirth BN, Van Soolingen D, Small PM: Genomic deletions classify the Beijing/W strains as a distinct genetic lineage of Mycobacterium tuberculosis. J Clin Microbiol 2005, 43(7):3185-3191.
• [20]Stavrum R, Valvatne H, Bo TH, Jonassen I, Hinds J, Butcher PD, Grewal HM: Genomic diversity among Beijing and non-Beijing Mycobacterium tuberculosis isolates from Myanmar. PLoS One 2008, 3(4):e1973.
• [21]Yuan X: The impact of the implementation of the DOTS strategy to TB control in Shihezi region. Endemic Diseases Bulletin 2010, 25(3):44-45. chinese title in the paper
• [22]Dou HY, Tseng FC, Lin CW, Chang JR, Sun JR, Tsai WS, Lee SY, Su IJ, Lu JJ: Molecular epidemiology and evolutionary genetics of Mycobacterium tuberculosis in Taipei. BMC Infect Dis 2008, 8:170. BioMed Central Full Text
• [23]Huard RC, Lazzarini LC, Butler WR, van Soolingen D, Ho JL: PCR-based method to differentiate the subspecies of the Mycobacterium tuberculosis complex on the basis of genomic deletions. J Clin Microbiol 2003, 41(4):1637-1650.
• [24]Kanduma E, McHugh TD, Gillespie SH: Molecular methods for Mycobacterium tuberculosis strain typing: a users guide. J Appl Microbiol 2003, 94(5):781-791.
• [25]Supply P, Allix C, Lesjean S, Cardoso-Oelemann M, Rusch-Gerdes S, Willery E, Savine E, de Haas P, van Deutekom H, Roring S, et al.: Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem repeat typing of Mycobacterium tuberculosis. J Clin Microbiol 2006, 44(12):4498-4510.
• [26]Banerjee R, Schecter GF, Flood J, Porco TC: Extensively drug-resistant tuberculosis: new strains, new challenges. Expert Rev Anti Infect Ther 2008, 6(5):713-724.
• [27]Kremer K, Glynn JR, Lillebaek T, Niemann S, Kurepina NE, Kreiswirth BN, Bifani PJ, van Soolingen D: Definition of the Beijing/W lineage of Mycobacterium tuberculosis on the basis of genetic markers. J Clin Microbiol 2004, 42(9):4040-4049.
• [28]Wei J, Wei Z, Weidong W, Xiaoming G, Jing Y, Yinuer A, Nianqiang L, Peng C: The report of WHO drug resistance surveillance on tuberculosis, Xinjiang. The Journal Of The Chinese Antituberculosis Association 2008, 30(4):307-310.
• [29]WHO/IUATLD: Anti-tuberculosis drug resistance in the world: The WHO/IUATLD global project on anti-tuberculosis drug resistance surveillance. WHO Report NO.4. 2008.
• [30]World Health Organization: Global tuberculosis control and patient care: a ministerial meeting of high M/XDR-TB burden countries. Beijing, China 2009.